Discover how innovative tumor therapies can change your life. Immerse yourself in authentic success stories and in-depth media reports that provide valuable insights into the CyberKnife and ZAP-X technology at ERCM.
Personal patient reports: Learn firsthand how we treat benign and malignant tumors – from acoustic neuromas to prostate cancer – on an outpatient basis and gently using modern radiosurgery.
Current media reports: Here we have compiled exciting interviews, current articles, press releases and reports on our pioneering work for you.
Your treatment success and your individual quality of life are our top priority. Arrange your personal consultation now!
"My world collapsed," recalls Torsten (57) of the moment he learned he was diagnosed with prostate cancer. Like him, many of our patients openly share their journey: from the initial diagnosis to the search for the best possible therapy to successful radiosurgical treatment.
Torsten's PSA level has dropped today. "You don't feel anything, it's completely painless, and it only takes 30 minutes," he says of his experience with CyberKnife therapy. "I would like to thank you very much. You are in very, very good hands here."
Here you will find more authentic stories that give courage and show why those affected like Torsten place their trust in us.
A patient shares his impressive experience with CyberKnife treatment at the ERCM.
A patient shares his impressive experience with CyberKnife treatment for prostate cancer at the European Radiosurgery Center Munich (ERCM).
Mr. Meier reports on his experiences with the treatment of his uveal melanoma at the CyberKnife Center Munich.
Here, a Mobil Oil KK patient describes her experience of CyberKnife treatment of a benign but critically located brain tumor.
“Treating my prostate cancer with the CyberKnife method has preserved my quality of life.”
My brain is my personality! I therefore wanted a safe and effective treatment without the side effects that would have been possible with an operation.
In 2012, I was diagnosed with Gleason 7 prostate cancer and the doctors recommended “active observation”.
The CyberKnife radiation did not hurt at all and only one session was necessary, which was over after 25 minutes.
I tolerated the outpatient treatment of my vascular tumor in the brain very well and went straight home afterwards on the subway.
The CyberKnife treatment enabled me to resume my mountain biking and climbing hobbies in a very short time.
All the other doctors I went to refused to treat me.
Stay informed: Here you'll find current press releases, interviews, articles, and TV reports about the European Radiosurgery Center Munich. In leading media outlets such as Spiegel, Bild, and Münchner Merkur, our renowned specialists provide insights into the benefits of innovative, patient-centered radiosurgery and its pioneering treatment methods.
This video shows a uveal melanoma treatment in cooperation with the University Eye Clinic Munich.
In this episode, we discuss the possibilities of CyberKnife treatment for renal cell carcinoma together with our experts from the University of Munich's Großhadern Hospital.
In this video, the treatment options of CyberKnife radiosurgery for patients with acoustic neuroma are discussed together with our neurosurgical colleagues from the Großhadern Clin...
In this episode we talk about the possibilities of CyberKnife treatment for the therapy of spinal tumors.
Radiosurgery with the Cyberknife for tumors and metastases TALK with Dr. Erich Lejeune, Dr. Martin Marianowizc and Professor Alexander Muacevic.
Christoph Gogg from München TV talks to Prof. Dr. Alexander Muacevic and his team at the ERCM about modern CyberKnife therapies for prostate cancer.
Radiosurgery with the CyberKnife for tumors and metastases TALK with Dr. Erich Lejeune, Dr. Martin Marianowizc and Professor Alexander Muacevic.
Surgery, chemotherapy, radiotherapy - these are the three forms of therapy that most people associate with cancer treatment. They all raise many questions and fears.
Munich doctors treat cancer patients with the world's most modern radiosurgery robot.
With around 63,000 new cases per year, prostate cancer is the most common type of cancer and the third most common cause of death from malignant diseases in men in Germany.
Mit dem System betreiben wir Radiochirurgie, also eine Behandlung mit Strahlen, auf höchster Präzisionsstufe.
After a serious heart valve disease, Gerhard D. (54) received another shock diagnosis: a brain tumor.